Table 2.
Summary of adverse events observed during the study
| Adverse event | Dexmedetomidine (n = 16) | Propofol (n = 10) | Total (n = 26) | |||
|---|---|---|---|---|---|---|
| Subjects, n (%) | Events, n | Subjects, n (%) | Events, n | Subjects, n (%) | Events, n | |
| Bradycardia | 1 (6.3) | 1 | 1 (3.8) | 1 | ||
| Cardiac arrest | 1 (10.0) | 1 | 1 (3.8) | 1 | ||
| Urinary tract infection | 1 (6.3) | 1 | 1 (3.8) | 1 | ||
| Decreased cough efficiency | 1 (10.0) | 1 | 1 (3.8) | 1 | ||
| Increased bronchial secretion | 1 (10.0) | 1 | 1 (3.8) | 1 | ||